These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 32028391)

  • 21. Pyoderma gangrenosum complicated with hematological malignancies: Two case reports.
    Li F; Zhao J; Duan H; Zhang H; Zhang L; Zhao L; Wen Y; Gu X
    Medicine (Baltimore); 2024 Mar; 103(10):e37159. PubMed ID: 38457569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyoderma gangrenosum in association with juvenile rheumatoid arthritis.
    Yayli S; Bahadir S; Alpay K; Cimşit G; Cobanoğlu U; Tosun M
    J Dermatol; 2005 Oct; 32(10):827-30. PubMed ID: 16361736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of pyoderma gangrenosum with ulcerative colitis treated with mesalazine.
    Lee JI; Park HJ; Lee JY; Cho BK
    Ann Dermatol; 2010 Nov; 22(4):422-5. PubMed ID: 21165212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery.
    Andrisani G; Guidi L; Papa A; Potenza AE; Cervelli D; Armuzzi A
    J Crohns Colitis; 2013 Jun; 7(5):421-6. PubMed ID: 22889645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pyoderma gangrenosum treated successfully with visilizumab in patients with ulcerative colitis].
    Lorincz M; Kleszky M; Szalóki T; Szalóki T
    Orv Hetil; 2010 Jan; 151(4):144-7. PubMed ID: 20071320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pyoderma gangrenosum: successful topical therapy with tacrolimus (FK506)].
    Petering H; Kiehl P; Breuer C; Kapp A; Werfel T
    Hautarzt; 2001 Jan; 52(1):47-50. PubMed ID: 11220239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pyoderma gangrenosum and systemic lupus erythematosus: A rare association].
    Magdoud O; Souissi A; Chelly I; Haouet S; Mokni M
    Rev Med Interne; 2020 Jan; 41(1):54-57. PubMed ID: 31495525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous manifestations in inflammatory bowel disease.
    Tromm A; May D; Almus E; Voigt E; Greving I; Schwegler U; Griga T
    Z Gastroenterol; 2001 Feb; 39(2):137-44. PubMed ID: 11253504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ulcerative colitis associated with pyoderma gangrenosum].
    Tusnádi A; Uhrin K; Bényei M; Krasznai G
    Orv Hetil; 1994 Apr; 135(17):917-9. PubMed ID: 7909938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ulcerative colitis complicated by pyoderma gangrenosum and multiple aseptic abscesses].
    Kita A; Hashimoto Y; Sato K; Itoi Y; Kasuga K; Tanaka H; Hosaka H; Kuribayashi S; Uraoka T
    Nihon Shokakibyo Gakkai Zasshi; 2022; 119(11):1014-1021. PubMed ID: 36351620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
    Kujundzić M
    Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical hemorrhagic bullous pyoderma gangrenosum.
    Altunay IK; Sezgin SA; Ileri U; Ekmekçi TR; Kuran I; Köşlü A; Baş L
    Int J Dermatol; 2001 May; 40(5):327-9. PubMed ID: 11554994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyoderma gangrenosum.
    Conrad C; Trüeb RM
    J Dtsch Dermatol Ges; 2005 May; 3(5):334-42. PubMed ID: 16372799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyoderma gangrenosum in an ulcerative colitis patient during treatment with vedolizumab responded favorably to adsorptive granulocyte and monocyte apheresis.
    Shibuya T; Haga K; Saeki M; Haraikawa M; Tsuchihashi H; Okahara K; Nomura O; Fukushima H; Murakami T; Ishikawa D; Ikeda S; Nagahara A
    J Clin Apher; 2020 Sep; 35(5):488-492. PubMed ID: 32767842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of Idiopathic Pyoderma Gangrenosum With Azathioprine As the Primary Adjunct in an Asian Man: A Case Report.
    Nazir A; Zafar A
    Cureus; 2022 May; 14(5):e25177. PubMed ID: 35746991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyoderma gangrenosum: an updated review.
    Ruocco E; Sangiuliano S; Gravina AG; Miranda A; Nicoletti G
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1008-17. PubMed ID: 19470075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary manifestations of pyoderma gangrenosum: 2 cases and a review of the literature.
    Gade M; Studstrup F; Andersen AK; Hilberg O; Fogh C; Bendstrup E
    Respir Med; 2015 Apr; 109(4):443-50. PubMed ID: 25622759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relapse of Ulcerative Colitis with Immune Thrombocytopenia and Pyoderma Gangrenosum Subsequent to Receiving COVID-19 Vaccination.
    Suzuki K; Aizawa M; Tamazawa K; Ueda K; Wada J; Nakajima Y; Shibukawa G; Ikeda S; Tsunoda S; Togashi K
    Intern Med; 2024 Mar; 63(5):665-669. PubMed ID: 38171870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review.
    Juillerat P; Christen-Zäch S; Troillet FX; Gallot-Lavallée S; Pannizzon RG; Michetti P
    Dermatology; 2007; 215(3):245-51. PubMed ID: 17823524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ulcerative colitis complicated by multiple aseptic subcutaneous abscesses: a case report].
    Kobayashi M; Ikezawa K; Iwai K; Ochi D; Otsuka K; Soeda A; Sugiyama H
    Nihon Shokakibyo Gakkai Zasshi; 2021; 118(7):671-678. PubMed ID: 34248080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.